Sign in

CIK 0001072379 · Non-accelerated filer<br>Smaller reporting company

NORTHWEST BIOTHERAPEUTICS INC

Sign in to watch
Ticker
NWBO
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943306718
Phone
(240) 497-9024
Business address
4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD, 20814
  1. SC 13G/A Stake Amended Statement of Ownership
  2. UPLOAD Other SEC-generated Letter
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Executive or director change · Shareholder vote results
  5. 4/A Open-market sale 10% owner sold 548,273 shares at an average $4.42 ($2,423,981)
  6. 4/A Open-market sale 10% owner sold 678,858 shares at an average $3.17 ($2,153,674)
  7. 8-K Event Regulation FD disclosure
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. 4 Open-market sale 10% owner sold 548,273 shares at an average $4.42 ($2,423,981)
  10. 4 Open-market sale 10% owner sold 678,858 shares at an average $3.17 ($2,153,674)
  11. 4 Open-market buy 10% owner bought 6,891,550 shares at $4.00 ($11,608,288)
  12. 4 Open-market sale 10% owner sold 860,000 shares at $1.08 ($928,800)
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Acquisition or sale completed
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. 10-Q/A Report 10-Q/A
  17. 8-K Event Regulation FD disclosure
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. DEF 14A Proxy Proxy Statement
  20. 10-Q Report Quarterly Report

Page 19 of 41 · 803 filings